- Zenflow secures $52M Series D financing to support commercialization of its Spring System
Zenflow secures $52M Series D financing to support commercialization of its Spring System
- InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
- Purple AI closes Series A, doubles valuation as it targets US stroke AI market
Purple AI closes Series A, doubles valuation as it targets US stroke AI market
- MiMedx to acquire Sanara MedTech in $350M deal to expand surgical portfolio
MiMedx has agreed to acquire Sanara MedTech in a cash-and-stock transaction with an enterprise value of approximately $350 million, expanding its presence in the surgical and regenerative medicine markets. As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on
- CoreMap raises $37M Series C led by Medtronic to advance AFib mapping technology
CoreMap has secured $37 million in an oversubscribed Series C financing round led by Medtronic to accelerate the development and commercialization of its next-generation atrial fibrillation (AFib) mapping platform. The company develops a high-density electrophysiology mapping system and advanced dat
- Navi raises A$6.8M to commercialize pediatric vascular access technology in the US
Navi Medical Technologies has raised A$6.8 million to support the US commercialization of its Neonav® vascular access technology following FDA 510(k) clearance and the start of clinical evaluations at two leading US children's hospitals. Led by KP Rx, with participation from Innovation Victoria and
- REEV launches pivotal clinical study of robotic knee brace to improve post-stroke mobility
REEV has initiated a pivotal clinical study evaluating DREEVEN, an intelligent robotic knee-ankle-foot orthosis designed to improve mobility and independence for stroke survivors with chronic gait impairment. The study, conducted with clinical partners including Encompass Health, Whittier Rehabilita
- Aurenar raises $5.7M seed round to advance neuromodulation technology
Aurenar has raised $5.7 million in an oversubscribed seed round to accelerate development of its V-Link noninvasive neuromodulation system, designed to reduce cerebral vasospasm in adults with aneurysmal subarachnoid hemorrhage (aSAH). The funding, co-led by the Go-Red for Women Venture Fund from Am
- Aqua Medical treats first patient in IDE trial for minimally invasive diabetes therapy
Aqua Medical has treated the first U.S. patient in its FDA investigational device exemption (IDE) trial evaluating its minimally invasive procedure for type 2 diabetes. The company’s proximal intestinal mucosal ablation (PIMA) procedure uses radiofrequency vapor ablation through a standard endoscope
- Dopl raises $6.3M seed round to advance remote robotic ultrasound platform
Dopl Technologies has raised $6.3 million in seed funding to accelerate development of its remote robotic ultrasound platform designed to expand access to diagnostic imaging. The Washington-based startup is developing a telerobotic system that enables sonographers to perform ultrasound exams remotel
- Xeltis raises €20.5M to advance aXess toward FDA approval and US launch
Xeltis has secured an additional €20.5 million in funding, led by Horizon 3 Healthcare, to advance its aXess™ vascular access implant toward FDA approval and US commercialization. The financing builds on the €50 million raised in 2025 and will support completion of the ongoing US pivotal trial, FDA
- Magnendo raises $18M Series A to advance magnetic robotic navigation for stroke care
MIT spinout Magnendo has raised $18M in a Series A round led by Penumbra to accelerate development of its magnetic robotic navigation platform for neuro-endovascular procedures. The technology combines magnetically steerable guidewires, robotic control, advanced imaging and AI-powered navigation sof
Market Insight
Evidence-Based Deep Dive
Top Picks
Latest MedTech News
MiMedx has agreed to acquire Sanara MedTech in a cash-and-stock transaction with an enterprise value of approximately $350 million, expanding its presence in the surgical and regenerative medicine markets.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on s
CoreMap has secured $37 million in an oversubscribed Series C financing round led by Medtronic to accelerate the development and commercialization of its next-generation atrial fibrillation (AFib) mapping platform.
The company develops a high-density electrophysiology mapping system and advanced data
Navi Medical Technologies has raised A$6.8 million to support the US commercialization of its Neonav® vascular access technology following FDA 510(k) clearance and the start of clinical evaluations at two leading US children's hospitals.
Led by KP Rx, with participation from Innovation Victoria and P
REEV has initiated a pivotal clinical study evaluating DREEVEN, an intelligent robotic knee-ankle-foot orthosis designed to improve mobility and independence for stroke survivors with chronic gait impairment.
The study, conducted with clinical partners including Encompass Health, Whittier Rehabilitat
Aurenar has raised $5.7 million in an oversubscribed seed round to accelerate development of its V-Link noninvasive neuromodulation system, designed to reduce cerebral vasospasm in adults with aneurysmal subarachnoid hemorrhage (aSAH).
The funding, co-led by the Go-Red for Women Venture Fund from Ame
Aqua Medical has treated the first U.S. patient in its FDA investigational device exemption (IDE) trial evaluating its minimally invasive procedure for type 2 diabetes.
The company’s proximal intestinal mucosal ablation (PIMA) procedure uses radiofrequency vapor ablation through a standard endoscope
Dopl Technologies has raised $6.3 million in seed funding to accelerate development of its remote robotic ultrasound platform designed to expand access to diagnostic imaging.
The Washington-based startup is developing a telerobotic system that enables sonographers to perform ultrasound exams remotely
Xeltis has secured an additional €20.5 million in funding, led by Horizon 3 Healthcare, to advance its aXess™ vascular access implant toward FDA approval and US commercialization.
The financing builds on the €50 million raised in 2025 and will support completion of the ongoing US pivotal trial, FDA s
MIT spinout Magnendo has raised $18M in a Series A round led by Penumbra to accelerate development of its magnetic robotic navigation platform for neuro-endovascular procedures.
The technology combines magnetically steerable guidewires, robotic control, advanced imaging and AI-powered navigation soft